Evaluation of the Protective Efficacy and Safety of CR8020 in an Influenza Challenge
Clinical trial NCT01938352 · COMPLETED
Trial details
- NCT number
- NCT01938352
- Sponsor
- Crucell Holland BV
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-02
- Primary completion
- 2014-01-22
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.